Anti-Cancerous Effect of Rutin Against HPV-C33A Cervical Cancer Cells via G0/G1 Cell Cycle Arrest and Apoptotic Induction

Author(s): Fahad Khan, Pratibha Pandey*, Tarun K. Upadhyay, Asif Jafri, Niraj K. Jha, Rashmi Mishra, Vineeta Singh.

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 20 , Issue 3 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Nowadays, the potential therapeutic role of various bioflavonoids including Curcumin, Luteolin and Resveratrol has currently been well-documented in a vast range of fatal complications including synaptic failure and cancers. These bioflavonoids are widely being implemented for the treatment of various cancers as they possess anti-cancerous, anti-oxidant and anti-inflammatory properties. Moreover, they are also used as a better alternative to conventional therapies since; these are non-toxic to cells and having no or least side effects. Notably, the pertinent therapeutic role of Rutin in cervical cancer is still unsettled however, its anti-cancerous role has already been reported in other cancers including prostate and colon cancer. Rutin (Vitamin P or Rutoside) is a polyphenolics flavonoid exhibiting multi-beneficial roles against several carcinomas.

Objective: Despite the evidence for its several biological activities, the anticancer effects of Rutin on human cervical cancer (C33A) cells remain to be explored. In this study, the anticancer potential of Rutin was investigated by employing the key biomarkers such as nuclear condensation reactive oxygen species (ROS), apoptosis, and changes in mitochondrial membrane potential (MMP).

Results: Our findings showed that Rutin treatment reduced the cell viability, induced significant increase in ROS production and nuclear condensation in dose-dependent manner. Moreover, Rutin provoked apoptosis by inducing decrease in MMP and activation of caspase-3. Cell cycle analysis further confirmed the efficacy of Rutin by showing cell cycle arrest at G0/G1 phase.

Conclusion: Thus, our study is envisaged to open up interests for elucidating Rutin as an anticancerous agent against cervical cancer.

Keywords: Cervical cancer, C33A, Rutin, apoptosis, cell cycle, ROS.

[1]
Li, J.; Zhang, Y.; Chen, L.; Lu, X.; Li, Z.; Xue, Y.; Guan, Y.Q. Cervical Cancer HeLa Cell Autocrine Apoptosis Induced by Coimmobilized IFN-γ plus TNF-α Biomaterials. ACS Appl. Mater. Interfaces, 2018, 10(10), 8451-8464.
[http://dx.doi.org/10.1021/acsami.7b18277] [PMID: 29436216]
[2]
Suzuki, Y.; Nakano, T.; Ohno, T.; Oka, K. Comparison of the radiobiological effect of carbon ion beam therapy and conventional radiation therapy on cervical cancer. J. Radiat. Res. (Tokyo), 2008, 49(5), 473-479.
[http://dx.doi.org/10.1269/jrr.07107] [PMID: 18622131]
[3]
Lorusso, D.; Petrelli, F.; Coinu, A.; Raspagliesi, F.; Barni, S. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol. Oncol., 2014, 133(1), 117-123.
[http://dx.doi.org/10.1016/j.ygyno.2014.01.042] [PMID: 24486604]
[4]
Cragg, G.M.; Newman, D.J. Natural products: a continuing source of novel drug leads. BiochimicaetBiophysicaActa (BBA)-. General Subjects, 2013, 1830(6), 3670-3695.
[http://dx.doi.org/10.1016/j.bbagen.2013.02.008]
[5]
Sak, K. Chemotherapy and dietary phytochemical agents. Chemother. Res. Pract., 2012. 2012282570
[http://dx.doi.org/10.1155/2012/282570] [PMID: 23320169]
[6]
Kozłowska, A.; Szostak-Węgierek, D. Flavonoids–Food Sources, Health Benefits, and Mechanisms Involved; Bioactive Molecules in Food, 2019, pp. 53-78.
[7]
Abdel-Raheem, I.T. Gastroprotective effect of rutin against indomethacin-induced ulcers in rats. Basic Clin. Pharmacol. Toxicol., 2010, 107(3), 742-750.
[http://dx.doi.org/10.1111/j.1742-7843.2010.00568.x] [PMID: 20374237]
[8]
Ali, M.S.; Mudagal, M.P.; Goli, D. Cardioprotective effect of tetrahydrocurcumin and rutin on lipid peroxides and antioxidants in experimentally induced myocardial infarction in rats. Pharmazie, 2009, 64(2), 132-136.
[PMID: 19320287]
[9]
Almeida, J.S.; Benvegnú, D.M.; Boufleur, N.; Reckziegel, P.; Barcelos, R.C.S.; Coradini, K.; de Carvalho, L.M.; Bürger, M.E.; Beck, R.C. Hydrogels containing rutin intended for cutaneous administration: efficacy in wound healing in rats. Drug Dev. Ind. Pharm., 2012, 38(7), 792-799.
[http://dx.doi.org/10.3109/03639045.2011.628676] [PMID: 22066462]
[10]
Alonso, C.; Rubio, L.; Touriño, S.; Martí, M.; Barba, C.; Fernández-Campos, F.; Coderch, L.; Parra, J.L. Antioxidative effects and percutaneous absorption of five polyphenols. Free Radic. Biol. Med., 2014, 75, 149-155.
[http://dx.doi.org/10.1016/j.freeradbiomed.2014.07.014] [PMID: 25041725]
[11]
Arima, H.; Ashida, H.; Danno, G. Rutin-enhanced antibacterial activities of flavonoids against Bacillus cereus and Salmonella enteritidis. Biosci. Biotechnol. Biochem., 2002, 66(5), 1009-1014.
[http://dx.doi.org/10.1271/bbb.66.1009] [PMID: 12092809]
[12]
Fernandes, A.A.H.; Novelli, E.L.B.; Okoshi, K.; Okoshi, M.P.; Di Muzio, B.P.; Guimarães, J.F.C.; Fernandes, Junior, A. Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed. Pharmacother., 2010, 64(3), 214-219.
[http://dx.doi.org/10.1016/j.biopha.2009.08.007] [PMID: 19932588]
[13]
Ganeshpurkar, A.; Saluja, A.K. The pharmacological potential of rutin. Saudi Pharm. J., 2017, 25(2), 149-164.
[http://dx.doi.org/10.1016/j.jsps.2016.04.025] [PMID: 28344465]
[14]
Pandey, P.; Sayyed, U.; Tiwari, R.K.; Siddiqui, M.H.; Pathak, N.; Bajpai, P. Hesperidin Induces ROS-Mediated Apoptosis along with Cell Cycle Arrest at G2/M Phase in Human Gall Bladder Carcinoma. Nutr. Cancer, 2018, 1-12.
[PMID: 30265812]
[15]
Khan, F.; Khan, I.; Farooqui, A.; Ansari, I.A. Carvacrol induces reactive oxygen species (ROS)-mediated apoptosis along with cell cycle arrest at G0/G1 in human prostate cancer cells. Nutr. Cancer, 2017, 69(7), 1075-1087.
[http://dx.doi.org/10.1080/01635581.2017.1359321] [PMID: 28872904]
[16]
Das, S.; Dey, K.K.; Dey, G.; Pal, I.; Majumder, A. MaitiChoudhury, S.; kundu, S.C.; Mandal, M. Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One, 2012, 7(10)e46641
[http://dx.doi.org/10.1371/journal.pone.0046641] [PMID: 23077516]
[17]
Pandey, P.; Bajpai, P.; Siddiqui, M.H.; Sayyed, U.; Tiwari, R.; Shekh, R.; Mishra, K.; Kapoor, V.K. Elucidation of the chemopreventive role of stigmasterol against Jab1 in Gall bladder carcinoma. Endocr. Metab. Immune Disord. Drug Targets, 2019.
[http://dx.doi.org/10.2174/1871530319666190206124120] [PMID: 30727937]
[18]
Olsson, M.; Zhivotovsky, B. Caspases and cancer. Cell Death Differ., 2011, 18(9), 1441-1449.
[http://dx.doi.org/10.1038/cdd.2011.30] [PMID: 21455218]
[19]
Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 2015, 136(5), E359-E386.
[http://dx.doi.org/10.1002/ijc.29210] [PMID: 25220842]
[20]
Kim, J.Y.; Byun, S.J.; Kim, Y.S.; Nam, J.H. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer. Gynecol. Oncol., 2017, 144(1), 34-39.
[http://dx.doi.org/10.1016/j.ygyno.2016.10.032] [PMID: 27789082]
[21]
Potential synergism of natural products in the treatment of cancer. Phytotherapy Research. An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 2006, 20(4), 239-249.
[22]
Lin, J.P.; Yang, J.S.; Lu, C.C.; Chiang, J.H.; Wu, C.L.; Lin, J.J.; Lin, H.L.; Yang, M.D.; Liu, K.C.; Chiu, T.H.; Chung, J.G. Rutin inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immune response in vivo. Leuk. Res., 2009, 33(6), 823-828.
[http://dx.doi.org/10.1016/j.leukres.2008.09.032] [PMID: 19010542]
[23]
Alonso-Castro, A.J.; Domínguez, F.; García-Carrancá, A. Rutin exerts antitumor effects on nude mice bearing SW480 tumor. Arch. Med. Res., 2013, 44(5), 346-351.
[http://dx.doi.org/10.1016/j.arcmed.2013.06.002] [PMID: 23867787]
[24]
Chen, H.; Miao, Q.; Geng, M.; Liu, J.; Hu, Y.; Tian, L.; Pan, J.; Yang, Y. Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. ScientificWorldJournal, 2013. 2013269165
[http://dx.doi.org/10.1155/2013/269165] [PMID: 24459422]
[25]
Araújo, J.R.; Gonçalves, P.; Martel, F. Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines. Nutr. Res., 2011, 31(2), 77-87.
[http://dx.doi.org/10.1016/j.nutres.2011.01.006] [PMID: 21419311]
[26]
Mouria, M.; Gukovskaya, A.S.; Jung, Y.; Buechler, P.; Hines, O.J.; Reber, H.A.; Pandol, S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int. J. Cancer, 2002, 98(5), 761-769.
[http://dx.doi.org/10.1002/ijc.10202] [PMID: 11920648]
[27]
Hengartner, M.O. The biochemistry of apoptosis. Nature, 2000, 407(6805), 770-776.
[http://dx.doi.org/10.1038/35037710] [PMID: 11048727]
[28]
Fulda, S.; Galluzzi, L.; Kroemer, G. Targeting mitochondria for cancer therapy. Nat. Rev. Drug Discov., 2010, 9(6), 447-464.
[http://dx.doi.org/10.1038/nrd3137] [PMID: 20467424]
[29]
Sun, S.Y.; Hail, N., Jr; Lotan, R. Apoptosis as a novel target for cancer chemoprevention. J. Natl. Cancer Inst., 2004, 96(9), 662-672.
[http://dx.doi.org/10.1093/jnci/djh123] [PMID: 15126603]
[30]
Hail, N., Jr; Lotan, R. Cancer chemoprevention and mitochondria: targeting apoptosis in transformed cells via the disruption of mitochondrial bioenergetics/redox state. Mol. Nutr. Food Res., 2009, 53(1), 49-67.
[http://dx.doi.org/10.1002/mnfr.200700527] [PMID: 19051186]
[31]
Clerkin, J.S.; Naughton, R.; Quiney, C.; Cotter, T.G. Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett., 2008, 266(1), 30-36.
[http://dx.doi.org/10.1016/j.canlet.2008.02.029] [PMID: 18372105]
[32]
Aleem, E.; Arceci, R.J. Targeting cell cycle regulators in hematologic malignancies. Front. Cell Dev. Biol., 2015, 3, 16.
[http://dx.doi.org/10.3389/fcell.2015.00016] [PMID: 25914884]
[33]
Kim, S.H.; Bae, H.C.; Park, E.J.; Lee, C.R.; Kim, B.J.; Lee, S.; Park, H.H.; Kim, S.J.; So, I.; Kim, T.W.; Jeon, J.H. Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Biochem. Biophys. Res. Commun., 2011, 407(1), 129-134.
[http://dx.doi.org/10.1016/j.bbrc.2011.02.124] [PMID: 21371438]
[34]
Lo, C.; Lai, T.Y.; Yang, J.H.; Yang, J.S.; Ma, Y.S.; Weng, S.W.; Chen, Y.Y.; Lin, J.G.; Chung, J.G. Gallic acid induces apoptosis in A375.S2 human melanoma cells through caspase-dependent and -independent pathways. Int. J. Oncol., 2010, 37(2), 377-385.
[PMID: 20596665]
[35]
Abdelmageed, N.; Morad, S.A.F.; Elghoneimy, A.A.; Syrovets, T.; Simmet, T.; El-Zorba, H.; El-Banna, H.A.; Cabot, M.; Abdel-Aziz, M.I. Oleanolic acid methyl ester, a novel cytotoxic mitocan, induces cell cycle arrest and ROS-Mediated cell death in castration-resistant prostate cancer PC-3 cells. Biomed. Pharmacother., 2017, 96, 417-425.
[http://dx.doi.org/10.1016/j.biopha.2017.10.027] [PMID: 29031200]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 3
Year: 2020
Page: [409 - 418]
Pages: 10
DOI: 10.2174/1871530319666190806122257
Price: $65

Article Metrics

PDF: 17
HTML: 2
EPUB: 2
PRC: 1